撤回：复方斑蝥胶囊联合索拉非尼对晚期肝细胞癌患者肝功能、免疫状态、生活质量改善及生存的影响：一项回顾性队列研究。
Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
作者信息
Intelligence And Neuroscience Computational
出版信息
Comput Intell Neurosci. 2023 Aug 2;2023:9817406. doi: 10.1155/2023/9817406. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/6336107.].
摘要
[本文撤回文章DOI: 10.1155/2022/6336107。]
相似文献
1
Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.撤回：复方斑蝥胶囊联合索拉非尼对晚期肝细胞癌患者肝功能、免疫状态、生活质量改善及生存的影响：一项回顾性队列研究。
Comput Intell Neurosci. 2023 Aug 2;2023:9817406. doi: 10.1155/2023/9817406. eCollection 2023.
2
[Proteomic analysis of differentially expressed proteins in human hepatoma SMMC-7721 cells induced by Fufang Banmao capsule serum].[复方斑蝥胶囊含药血清诱导人肝癌SMMC-7721细胞差异表达蛋白质的蛋白质组学分析]
Zhongguo Zhong Yao Za Zhi. 2007 May;32(9):831-4.
3
Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment.胶囊，一种中药配方，可提高支持治疗的肝细胞癌和 Vp3-4 门静脉癌栓患者的生存率。
J Altern Complement Med. 2020 Oct;26(10):956-965. doi: 10.1089/acm.2019.0334. Epub 2020 Jul 2.
4
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.钇[90Y]树脂微球选择性内放射治疗与索拉非尼治疗局部进展期不可切除肝细胞癌的疗效和安全性比较（SARAH）：一项开放标签随机对照 3 期临床试验。
Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26.
5
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.辅助中药治疗对肝癌患者长期生存的影响。
Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11.
6
Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment.接受索拉非尼治疗的晚期肝细胞癌患者健康相关生活质量的纵向变化及其对临床病程的影响。
BMC Cancer. 2016 Nov 11;16(1):878. doi: 10.1186/s12885-016-2908-7.
7
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis.索拉非尼作为晚期 Child-Pugh B 级肝细胞癌患者的一线治疗方法：一项荟萃分析。
Eur J Cancer. 2018 Dec;105:1-9. doi: 10.1016/j.ejca.2018.09.031. Epub 2018 Oct 29.
8
A real-life experience of sorafenib treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis at Cathay General Hospital, 2007-2015.索拉非尼治疗晚期肝细胞癌患者的真实临床经验：国泰综合医院2007 - 2015年回顾性分析
Drug Des Devel Ther. 2019 Jan 22;13:397-404. doi: 10.2147/DDDT.S191334. eCollection 2019.
9
Retracted: Studying the Role and Molecular Mechanisms of in Sorafenib Resistance of Hepatocellular Carcinoma.撤回：研究[具体内容缺失]在肝细胞癌索拉非尼耐药中的作用及分子机制。
Biomed Res Int. 2024 Mar 20;2024:9760191. doi: 10.1155/2024/9760191. eCollection 2024.
10
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma.普伐他汀联合索拉非尼不能改善晚期肝细胞癌的生存。
J Hepatol. 2019 Sep;71(3):516-522. doi: 10.1016/j.jhep.2019.04.021. Epub 2019 May 22.
本文引用的文献
1
Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.复方斑蝥胶囊联合索拉非尼对晚期肝癌患者肝功能、免疫状态、生活质量改善及生存的影响：一项回顾性队列研究。
Comput Intell Neurosci. 2022 Aug 23;2022:6336107. doi: 10.1155/2022/6336107. eCollection 2022.
Zotero 插件